HSD17B6 delays type 2 diabetes development via inhibiting SREBP activation
{{output}}
Background: The SREBP/SCAP/INSIG complex plays an essential role in SREBP activation and de novo lipogenesis. Whether the activation process is affected by hydroxysteroid 17-beta dehydrogenase 6 (HSD17B6) remains unknown. ... ...
